Kalshi, a prediction betting market app, announced new contracts in July 2026 for FDA approvals on various cancer and ...

In HELIOS-B (n=654), baseline tafamidis use (40%) did not significantly modify vutrisiran’s effect on mortality plus ...

Hospital resources, not clinical preference, often decide which MG rescue therapy a patient receives, Richard Nowak, MD, MS, ...

REMS certification requirements, split hospital/community EMRs, and limited trained infusion staffing create friction points ...

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press. In its article, Becker's ...

In "The Next Frontier in Hepatitis B Functional and Virologic Cure," our experts look ahead to the combination strategies and ...

FDA late today granted accelerated approval to camizestrant for firstline treatment of patients with ER-positive, HER2-negative metastatic breast cancer with ESR1 mutations. 1 The action comes more ...

Seshadri, who moderated a discussion at the August 11 Institute for Value-Based Medicine ® event in San Francisco, said travel distance to a CAR T-cell center is a major barrier, compounded by ...

Andrew Kuykendall, MD, lead investigator for the VERIFY trial supporting the approval, said rusfertide is used to treat erythrocytosis in polycythemia vera.

Keith Bellovich, DO, of Strive Health, discusses how the new CKM guideline unifies cardiology, nephrology, and endocrinology ...

August authors Jeff Romine, PhD, and Kofi Essel, MD, MPH, found grocery assistance linked to fewer diabetes complications and ...

T-cell therapy, access remains a significant challenge, particularly because the treatment is still largely conce ...